BHP Billiton Limited vs Cassava Sciences Inc — how do they compare? BHP Billiton Limited trades at $90.59 (market cap $229.15B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: BHP Billiton Limited is far larger — about 4799× Cassava Sciences Inc's market cap, and BHP Billiton Limited pays a 2.95% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| BHP | FLNA | |
|---|---|---|
Market Cap | $229.15B | $47.75M |
Sector | Basic Materials | Health |
52-Week High | $93.15 | $4.64 |
52-Week Low | $52.14 | $0.87 |
Enterprise Value | $243.35B | -$34.93M |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
BHP trades at $90.61, up 0.22% with a bullish technical signal supported by moving averages. The company reported mixed Q4 2025 earnings, missing EPS estimates but maintaining strong profitability with 18.97% net margins. Recent operational challenges include strikes at Port Hedland iron ore operations, while copper production declines in Chile. Valuation metrics show a P/E of 22.36 and P/B of 4.54, reflecting premium pricing relative to historical levels.
The outlook remains cautiously optimistic with analyst consensus leaning hold (64.52%) amid labor disputes and production volatility. Key opportunities include exposure to AI-driven copper demand growth, while risks center on strike impacts and fluctuating commodity prices. The stock's current technical strength faces fundamental headwinds from operational disruptions.
FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.
The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.
Trailing returns across standard periods
BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.
Read more on BHP →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →